Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-2016 | 06-2016 | 05-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -346 | -85 | -264 | -68 | N/A |
| Depreciation Amortization | 73 | N/A | 55 | N/A | N/A |
| Accounts receivable | 412 | N/A | 532 | N/A | N/A |
| Accounts payable and accrued liabilities | -152 | -4 | -145 | 14 | N/A |
| Other Working Capital | 375 | -4 | 462 | 14 | N/A |
| Other Operating Activity | -260 | 26 | -386 | 20 | 0 |
| Operating Cash Flow | $101 | $-67 | $253 | $-21 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -55 | N/A | -36 | N/A | N/A |
| Other Investing Activity | -407 | 0 | -404 | 0 | 0 |
| Investing Cash Flow | $-462 | $0 | $-440 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | 473 | N/A | N/A |
| Common Stock Issued | N/A | 70 | N/A | 40 | N/A |
| Other Financing Activity | 402 | 0 | -48 | 0 | 0 |
| Financing Cash Flow | $402 | $70 | $425 | $40 | $N/A |
| Exchange Rate Effect | 1 | N/A | 1 | N/A | N/A |
| Beginning Cash Position | 68 | 14 | 68 | 14 | N/A |
| End Cash Position | 110 | 18 | 307 | 34 | N/A |
| Net Cash Flow | $42 | $3 | $239 | $19 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 101 | -67 | 253 | -21 | N/A |
| Capital Expenditure | -55 | N/A | -36 | N/A | N/A |
| Free Cash Flow | 46 | -67 | 217 | -21 | 0 |